Bruker (BRKR) Income from Non-Controlling Interests (2010 - 2026)
Bruker (BRKR) posted Income from Non-Controlling Interests of $1.3 million for Q1 2026, down 59.38% on a QoQ basis from $3.2 million in Q4 2025, and up 316.67% year-over-year from $312000.0 in Q1 2025.
Bruker (BRKR) Income from Non-Controlling Interests (2010 - 2026) Analysis & Trends
Bruker's Income from Non-Controlling Interests history runs 17 years deep, the most recent figure standing at $1.3 million for Q1 2026.
- Quarterly Income from Non-Controlling Interests rose 316.67% year-over-year to $1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.2 million (up 320.0% YoY) and the FY2025 annual result came in at $300000.0, down 57.14% from the prior year.
- Income from Non-Controlling Interests was $1.3 million for Q1 2026 at Bruker, down from $3.2 million in the prior quarter.
- Across five years, Income from Non-Controlling Interests topped out at $3.2 million in Q4 2022 and bottomed at -$3.4 million in Q2 2025.
- A 5-year average of $443750.0 and a median of $550000.0 in 2022 frame the typical range for Income from Non-Controlling Interests.
- Annual changes were most pronounced in 2024 — Income from Non-Controlling Interests plunged 200.0% — and 2025, when it jumped 1500.0%.
- Bruker's Income from Non-Controlling Interests stood at $3.2 million in 2022, then tumbled by 128.12% to -$900000.0 in 2023, then surged by 122.22% to $200000.0 in 2024, then soared by 1500.0% to $3.2 million in 2025, then slumped by 59.38% to $1.3 million in 2026.
- Business Quant data shows BRKR's Income from Non-Controlling Interests at $1.3 million in Q1 2026, $3.2 million in Q4 2025, and $1.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.14 Bn | 173.84 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.35 Bn | 125.47 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.95 Bn | 98.73 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 68.16 Bn | 66.71 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 47.67 Bn | 44.00 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.17 Bn | 1.98 Bn | 22.00 Mn |
| 7 | Dexcom | 28.45 Bn | 27.33 Bn | 750.30 Mn | - |
| 8 | Smith & Nephew | 26.83 Bn | 26.25 Bn | - | - |
| 9 | Koninklijke Philips | 25.36 Bn | 22.23 Bn | 2.07 Bn | -5.85 Mn |
| 10 | Bruker | 9.18 Bn | 9.18 Bn | 379.80 Mn | 1.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.30 Mn |
| Dec 31, 2025 | 3.20 Mn |
| Sep 30, 2025 | 1.10 Mn |
| Jun 30, 2025 | -3.40 Mn |
| Mar 31, 2025 | -600,000.00 |
| Dec 31, 2024 | 200,000.00 |
| Sep 30, 2024 | -600,000.00 |
| Mar 31, 2024 | 1.10 Mn |
| Dec 31, 2023 | -900,000.00 |
| Sep 30, 2023 | 600,000.00 |
| Jun 30, 2023 | 700,000.00 |
| Mar 31, 2023 | 900,000.00 |
| Dec 31, 2022 | 3.20 Mn |
| Sep 30, 2022 | 300,000.00 |
| Jun 30, 2022 | -500,000.00 |
| Mar 31, 2022 | 500,000.00 |
| Dec 31, 2021 | 300,000.00 |
| Sep 30, 2021 | 1.00 Mn |
| Mar 31, 2021 | 900,000.00 |
| Dec 31, 2020 | 2.40 Mn |